Physician profile
Renee E Reeder
NPI 1871586289
$26,650.35
in general payments reported to CMS, 2019-2025
17 companies · $4,406 in 2025
The $4,406 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,807 · 2020: $4,557 · 2021: $8,036 · 2022: $1,067 · 2023: $504 · 2024: $6,274 · 2025: $4,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,140 · Food and Beverage: $1,973 · Consulting Fee: $1,600 · Travel and Lodging: $1,465 · Education: $4.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,140.00 |
| Food and Beverage | $1,973.29 |
| Consulting Fee | $1,600.00 |
| Travel and Lodging | $1,464.97 |
| Education | $4.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $19,182.93 | 2020-2025 | Synergeyes Contact Lens, Onefit Contact Lens, Paragon Crt |
| Alcon Vision LLC | $2,596.91 | 2019-2025 | Precision 7, Air Optix, Tryptyr |
| Bausch & Lomb Americas INC. | $1,735.72 | 2024-2025 | Zenlens, Miebo, Xiidra |
| The Walman Optical Company | $1,019.00 | 2020 | |
| Abbvie INC. | $619.73 | 2022-2025 | |
| Allergan, INC. | $397.79 | 2019-2021 | |
| Visionix USA, INC | $362.00 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $310.48 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $114.34 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $112.50 | 2022-2024 | Acuvue |
| Lombart Brothers, INC. | $52.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $49.65 | 2019 | |
| Ocular Therapeutix, INC. | $25.06 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $22.36 | 2024 | Xdemvy |
| Genzyme Corporation | $21.80 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $15.81 | 2021 | |
| Derma Sciences, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Reeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.